LETTERS
TO THE EDITOR et al. reported that the increase in serum T4 induced by the TRH infusion was less in vibration syndrome patients than the normal levels for healthy subjects.2) Harada et al. in investigating thyroid function in vibration syndrome patients and healthy subjects found that patients with vibration syndrome showed low T3 syndrome.3) They speculated that these findings were due to a hypothalamus dysfunction in patients with vibration syndrome. In the present study, the concentration of T3 before the infusion was not significantly different between patients and controls. One of the reasons may have been that the vibration syndrome subjects were new outpatients whose disease was still relatively mild. We designed this study to examine patients who had not yet shown effect of medical treatment. In many cases, patients who have severe vibration syndrome have other systemic complications with aging. We excluded the patients with complications such as hypertension, heart diseases, diabetes mellitus and so on.
Since we excluded patients with such heavy disorders in this study, the vibration syndrome conditions of those tested were not severe. The other reason is that the number of vibration syndrome patients with severe conditions who have recently been diagnosed in Japan has decreased due to efforts to prevent vibration syndrome.6,7)
There is an interaction between catecholamines and thyroid hormones.8,9 In a previous study, we studied plasma catecholamines to evaluate the sympathetic nervous system in vibration syndrome. It showed more activity under cold conditions than in healthy controls.10) We suspect that low T3 syndrome in the patients with vibration syndrome might be caused by the interaction between catecholamines and thyroid hormones. Besides this, the interaction in vibration syndrome patients must be investigated.
In conclusion this study found the responses of pituitary-thyroid system to the TRH infusion in vibration syndrome patients to be similar to healthy subjects. The TRH test could not detect any significant differences in pituitary-thyroid function between vibration syndrome patients and healthy controls. 
